• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

未经辅助放疗治疗的临床II期或III期直肠癌患者的预后。

Outcome of patients with clinical stage II or III rectal cancer treated without adjuvant radiotherapy.

作者信息

Fujita Shin, Yamamoto Seiichiro, Akasu Takayuki, Moriya Yoshihiro

机构信息

Department of Surgery, National Cancer Center Hospital, 1-1 Tukiji 5-chome, Chuo-ku, Tokyo 104-0045, Japan.

出版信息

Int J Colorectal Dis. 2008 Nov;23(11):1073-9. doi: 10.1007/s00384-008-0513-1. Epub 2008 Jul 2.

DOI:10.1007/s00384-008-0513-1
PMID:18594841
Abstract

BACKGROUND

To clarify the indications for preoperative adjuvant radiotherapy for rectal cancer, the outcome of patients who underwent curative surgery without adjuvant radiotherapy was investigated.

METHODS

A total of 817 consecutive patients who underwent curative surgery for clinical stage II or III rectal cancer without preoperative adjuvant radiotherapy between 1988 and 2002 were reviewed.

RESULTS

The actuarial 5-year local recurrence rate in the examined patients was 6.2%. Univariate analysis showed that sex, pathological T classification (pT), clinical N classification (cN), pathological N classification (pN), tumor site, distance from the anal verge, type of surgery, pathological stage, a positive radical margin, lymphatic invasion, and venous invasion were significantly correlated with local recurrence. Multivariate analysis of preoperative factors identified cN, distance from the anal verge, and sex as statistically significant risk factors for local recurrence. In patients with rectal cancer located less than 5 cm from the anal verge and with positive cN, the local recurrence rate was more than 10%.

CONCLUSIONS

Patients with rectal cancer located less than 5 cm from the anal verge and with clinically positive lymph nodes should be given preoperative adjuvant radiotherapy.

摘要

背景

为明确直肠癌术前辅助放疗的适应证,对未接受辅助放疗而行根治性手术的患者的结局进行了调查。

方法

回顾了1988年至2002年间连续817例未接受术前辅助放疗而行临床II期或III期直肠癌根治性手术的患者。

结果

所检查患者的精算5年局部复发率为6.2%。单因素分析显示,性别、病理T分期(pT)、临床N分期(cN)、病理N分期(pN)、肿瘤部位、距肛缘距离、手术类型、病理分期、切缘阳性、淋巴管浸润和静脉浸润与局部复发显著相关。术前因素的多因素分析确定cN、距肛缘距离和性别为局部复发的统计学显著危险因素。对于距肛缘小于5 cm且cN阳性的直肠癌患者,局部复发率超过10%。

结论

距肛缘小于5 cm且临床淋巴结阳性的直肠癌患者应接受术前辅助放疗。

相似文献

1
Outcome of patients with clinical stage II or III rectal cancer treated without adjuvant radiotherapy.未经辅助放疗治疗的临床II期或III期直肠癌患者的预后。
Int J Colorectal Dis. 2008 Nov;23(11):1073-9. doi: 10.1007/s00384-008-0513-1. Epub 2008 Jul 2.
2
Rectal cancer: local recurrence after surgery without radiotherapy.直肠癌:术后未行放疗的局部复发
Dis Colon Rectum. 2001 Mar;44(3):374-9. doi: 10.1007/BF02234736.
3
Is there a need for neoadjuvant short-course radiotherapy in T3 rectal cancer with positive lymph node involvement? A single-center retrospective cohort study.局部进展期 T3 直肠癌伴阳性淋巴结转移行新辅助短程放疗的必要性:单中心回顾性队列研究
World J Surg Oncol. 2019 Aug 8;17(1):139. doi: 10.1186/s12957-019-1670-0.
4
Effect of adjuvant radiotherapy on local recurrence in stage II rectal cancer.辅助放疗对II期直肠癌局部复发的影响。
Ann Surg Oncol. 2008 Feb;15(2):519-25. doi: 10.1245/s10434-007-9643-x. Epub 2007 Oct 25.
5
Preoperative radiotherapy improves survival for patients undergoing total mesorectal excision for stage T3 low rectal cancers.术前放疗可提高接受全直肠系膜切除术的T3期低位直肠癌患者的生存率。
Ann Surg. 2002 Aug;236(2):203-7. doi: 10.1097/00000658-200208000-00008.
6
Predictors of recurrence after local excision and postoperative chemoradiation therapy of adenocarcinoma of the rectum.直肠癌局部切除及术后放化疗后复发的预测因素
Ann Surg Oncol. 1999 Jan-Feb;6(1):26-32. doi: 10.1007/s10434-999-0026-3.
7
Local excision and postoperative radiotherapy for distal rectal cancer.低位直肠癌的局部切除及术后放疗
Int J Radiat Oncol Biol Phys. 2001 Aug 1;50(5):1309-16. doi: 10.1016/s0360-3016(01)01545-0.
8
Complete pathologic response following preoperative chemoradiation therapy for middle to lower rectal cancer is not a prognostic factor for a better outcome.中低位直肠癌术前放化疗后的完全病理缓解并非预后更好的预测因素。
Dis Colon Rectum. 2004 Nov;47(11):1798-807. doi: 10.1007/s10350-004-0681-1.
9
[Radical surgery combined with adjuvant radiotherapy for elderly patients aged over 75 years with stage II( or III( rectal cancer: a retrospective study from a single center].75岁以上老年II期(或III期)直肠癌患者的根治性手术联合辅助放疗:一项单中心回顾性研究
Zhonghua Wei Chang Wai Ke Za Zhi. 2018 Jun 25;21(6):654-659.
10
Intersphincteric resection for very low rectal adenocarcinoma: univariate and multivariate analyses of risk factors for recurrence.超低位直肠腺癌的括约肌间切除术:复发危险因素的单因素和多因素分析
Ann Surg Oncol. 2008 Oct;15(10):2668-76. doi: 10.1245/s10434-008-0047-3. Epub 2008 Jul 10.

引用本文的文献

1
Mechanisms and Clinical Significance of Tumor Lymphatic Invasion.肿瘤淋巴管侵犯的机制及临床意义。
Cells. 2021 Sep 29;10(10):2585. doi: 10.3390/cells10102585.
2
Left colon as a novel high-risk factor for postoperative recurrence of stage II colon cancer.左半结肠癌是 II 期结肠癌术后复发的一个新的高危因素。
World J Surg Oncol. 2020 Mar 11;18(1):54. doi: 10.1186/s12957-020-01818-7.
3
Pathological complete response after preoperative chemotherapy including FOLFOX plus bevacizumab for locally advanced rectal cancer: A case report and literature review.

本文引用的文献

1
Risk factors for adverse outcome in patients with rectal cancer treated with an abdominoperineal resection in the total mesorectal excision trial.全直肠系膜切除试验中接受腹会阴联合切除术治疗的直肠癌患者不良结局的危险因素。
Ann Surg. 2007 Jul;246(1):83-90. doi: 10.1097/01.sla.0000259432.29056.9d.
2
Risk factors for faecal incontinence after rectal cancer treatment.直肠癌治疗后大便失禁的危险因素。
Br J Surg. 2007 Oct;94(10):1278-84. doi: 10.1002/bjs.5819.
3
Prognostic groups in 1,676 patients with T3 rectal cancer treated without preoperative radiotherapy.
术前化疗(包括FOLFOX方案联合贝伐单抗)后局部晚期直肠癌达到病理完全缓解:一例病例报告及文献综述
Int J Surg Case Rep. 2019;62:85-88. doi: 10.1016/j.ijscr.2019.08.010. Epub 2019 Aug 17.
4
A prospective feasibility study to evaluate neoadjuvant-synchronous S-1 with radiotherapy for locally advanced rectal cancer: A multicentre phase II trial.一项评估新辅助同步S-1联合放疗治疗局部晚期直肠癌的前瞻性可行性研究:一项多中心II期试验。
Mol Clin Oncol. 2016 Apr;4(4):510-514. doi: 10.3892/mco.2016.767. Epub 2016 Feb 4.
5
Case-matched comparison of the short-term outcomes between laparoscopic and open abdominoperineal resection for rectal cancer.腹腔镜与开腹经腹会阴联合切除术治疗直肠癌的短期疗效对比的病例匹配研究。
Surg Today. 2014 Apr;44(4):640-5. doi: 10.1007/s00595-013-0611-8. Epub 2013 May 14.
6
Clinical characteristics of rectal cancer involving the anal canal.累及肛管的直肠癌的临床特征。
J Gastrointest Surg. 2011 Mar;15(3):460-5. doi: 10.1007/s11605-010-1393-6. Epub 2010 Nov 30.
7
Adjuvant radiotherapy following total mesorectal excision for stage IIA rectal cancer: is it beneficial?全直肠系膜切除术后辅助放疗治疗 IIA 期直肠癌:是否有益?
Int J Colorectal Dis. 2010 Sep;25(9):1103-10. doi: 10.1007/s00384-010-0970-1. Epub 2010 Jun 11.
8
Improving prediction of lateral node spread in low rectal cancers--multivariate analysis of clinicopathological factors in 1,046 cases.提高低位直肠癌侧方淋巴结转移预测率——1046 例临床病理因素的多因素分析。
Langenbecks Arch Surg. 2010 Jun;395(5):545-9. doi: 10.1007/s00423-010-0642-1. Epub 2010 Apr 2.
9
Regional lymph node metastasis and locoregional recurrence of rectal carcinoma in the era of TME [corrected] surgery. Implications for treatment decisions.直肠肿瘤系膜全切除术时代的区域淋巴结转移和局部复发。对治疗决策的影响。 (注意:原文中的方括号内的内容是编辑为了纠正错误而添加的,译文保留了这些方括号。)
Int J Colorectal Dis. 2010 Mar;25(3):359-68. doi: 10.1007/s00384-009-0864-2. Epub 2009 Dec 10.
1676例未接受术前放疗的T3期直肠癌患者的预后分组
Dis Colon Rectum. 2007 Feb;50(2):156-67. doi: 10.1007/s10350-006-0757-1.
4
Can pelvic radiotherapy be omitted in select patients with rectal cancer?部分直肠癌患者能否省略盆腔放疗?
Semin Oncol. 2006 Dec;33(6 Suppl 11):S70-4. doi: 10.1053/j.seminoncol.2006.10.019.
5
Should preoperative or postoperative therapy be administered in the management of rectal cancer?直肠癌的治疗中应进行术前还是术后治疗?
Semin Oncol. 2006 Dec;33(6 Suppl 11):S64-9. doi: 10.1053/j.seminoncol.2006.10.018.
6
Late adverse effects of short-course preoperative radiotherapy in rectal cancer.直肠癌短程术前放疗的晚期不良反应
Br J Surg. 2006 Dec;93(12):1519-25. doi: 10.1002/bjs.5525.
7
Preoperative radiotherapy with or without concurrent fluorouracil and leucovorin in T3-4 rectal cancers: results of FFCD 9203.T3-4期直肠癌术前放疗联合或不联合氟尿嘧啶及亚叶酸钙:FFCD 9203研究结果
J Clin Oncol. 2006 Oct 1;24(28):4620-5. doi: 10.1200/JCO.2006.06.7629.
8
Long-term results of a randomized trial comparing preoperative short-course radiotherapy with preoperative conventionally fractionated chemoradiation for rectal cancer.一项比较术前短程放疗与术前常规分割放化疗治疗直肠癌的随机试验的长期结果
Br J Surg. 2006 Oct;93(10):1215-23. doi: 10.1002/bjs.5506.
9
Chemotherapy with preoperative radiotherapy in rectal cancer.直肠癌术前放疗联合化疗
N Engl J Med. 2006 Sep 14;355(11):1114-23. doi: 10.1056/NEJMoa060829.
10
Long-term functional and quality of life outcomes after coloanal anastomosis for distal rectal cancer.低位直肠癌结肠肛管吻合术后的长期功能及生活质量结局
Dis Colon Rectum. 2006 Sep;49(9):1266-74. doi: 10.1007/s10350-006-0640-0.